PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

EASL publishes revised clinical practice guidelines to optimise the management of hepatitis C virus

2013-12-09
(Press-News.org) Contact information: Courtney Lock
easlpressoffice@cohnwolfe.com
44-207-331-5317
European Association for the Study of the Liver
EASL publishes revised clinical practice guidelines to optimise the management of hepatitis C virus

The European Association for the Study of the Liver (EASL) today publishes their revised Clinical Practice Guidelines (CPGs) on the management of hepatitis C virus infection (HCV) (1). The EASL guidelines, which supersede the previous version published in 2011, are designed to help physicians and other healthcare providers optimise their management of patients with acute and chronic HCV.

It is estimated that approximately 160 million individuals, i.e. 2.35% of the world's population, are chronically infected with HCV. In the European Union alone, between 7.3 and 8.8 million people are infected with HCV, double the previous estimate made in 1997. The prevalence varies across the region with higher rates seen in the south and the east, making HCV a critical area of attention for hepatologists as one fifth of HCV-infected patients are at risk of developing cirrhosis or liver cancer (2).

HCV CPG co-chair reviewer and consultant hepatologist at Queen Elizabeth Hospital, Birmingham, Professor David Mutimer said: "As our understanding of HCV increases and therapies evolve, more complex treatment strategies are necessary to achieve the primary goal of curing the infection.

"Since EASL published the last HCV CPG in 2011, two protease inhibitors have been approved for use in patients infected with HCV genotype 1. These first-generation direct-acting antivirals are the first of many direct acting antiviral drugs which will revolutionise treatment for HCV patients, including those who failed to respond to previous therapies. The new guidelines provide essential information on the recommended use of these newly licensed drugs to help prescribers deliver optimal care for their HCV patients."

Based on a systematic review of existing literature, the CPGs provide best practice recommendations on a number of key areas:

Current standard of care and developing therapies Diagnosis of acute and chronic hepatitis C Goals and endpoints of HCV therapy Indications for treatment and who should be treated Treatment strategies for different viral genotypes Treatment monitoring including virological response-guided triple, and dual therapy Monitoring treatment safety Treatment of special groups including HIV co-infection, hepatitis B co-infection and patients with other co-morbidities such as severe liver disease

The guidelines also contain significant discussion about people who inject drugs (PWID*) providing an overview of the published literature relating to the treatment of these patients, and covering issues such as:



Re-infection following successful HCV treatment in patients at high risk (such as PWID) The burden of chronic HCV and advanced liver disease among ageing cohorts of PWID

Professor Mutimer added: "With HCV spread among PWID now accounting for the vast majority of incident cases in developed countries, and with modelling studies suggesting that treatment for PWID could reduce transmission, it is critical that physicians review and adopt these guidelines when managing this important group of patients."

Commenting on the CPGs, EASL Secretary General Professor Markus Peck-Radosavljevic said "EASL is dedicated to promoting hepatology research and education to improve the worldwide treatment of liver disease. As treatment for hepatitis C continues to progress rapidly with the development and approval of new therapies, it's vital to ensure that our series of Clinical Practice Guidelines reflect best practice to drive better clinical outcomes.

"As there have been several key clinical and scientific advances over the past two years, these guidelines build upon the recommendations reported by the EASL HCV panel of experts in 2011. EASL encourage clinicians to refer to these new HCV guidelines for the most up-to-date, evidence based methods to offer patients first class treatment."



INFORMATION:

The guidelines will also be published in the Journal of Hepatology (Vol. 60 Issue. 2 February, 2014) and presented during a session of the International Liver CongressTM 2014 in London (April 9 – 13).

About EASL

EASL is the leading European scientific society involved in promoting research and education in hepatology. EASL attracts the foremost hepatology experts and has an impressive track record in promoting research in liver disease, supporting wider education and promoting changes in European liver policy.

EASL's main focus on education and research is delivered through numerous events and initiatives, including:

The International Liver CongressTM which is the main scientific and professional event in hepatology worldwide Meetings including Monothematic and Special conferences, Post Graduate Courses and other endorsed meetings that take place throughout the year Clinical and Basic Schools of Hepatology, a series of events covering different aspects in the field of hepatology Journal of Hepatology published monthly Participation in a number of policy initiatives at European level

*PWID refers to recreational drug use

1. Mutimer D. et al. (2013) EASL Clinical Practice Guidelines: Management of Hepatitis C virus infection. Available at http://www.easl.eu/_clinical-practice-guideline

2. Hepatitis. Net Doctor. Available at http://www.netdoctor.co.uk/diseases/facts/hepatitis.htm. Accessed 25 November 2013.



ELSE PRESS RELEASES FROM THIS DATE:

Breakthrough in treating leukemia, lymphoma with umbilical cord blood stem cells

2013-12-09
Breakthrough in treating leukemia, lymphoma with umbilical cord blood stem cells Study finds that growing stem cells in lab before transplant boosts survival MAYWOOD, Il. - Donated umbilical cord blood contains stem cells that can save the lives of patients with ...

Pioneering path to electrical conductivity in 'tinker toy' materials to appear in Science

2013-12-09
Pioneering path to electrical conductivity in 'tinker toy' materials to appear in Science LIVERMORE, Calif.— Sandia National Laboratories researchers have devised a novel way to realize electrical conductivity in metal-organic framework (MOF) materials, a development ...

Study shows first link between altitude and concussion

2013-12-09
Study shows first link between altitude and concussion Athletes experience fewer concussions at higher elevations AURORA, Colo. (Dec. 9, 2013) – A new study shows that high school athletes playing at higher altitudes suffer fewer concussions than those closer ...

Inflammation in prostate may reduce cancer risk

2013-12-09
Inflammation in prostate may reduce cancer risk MANHASSET, NY – Doctors at the North Shore-LIJ Health System have discovered that increased inflammation in the prostate may predict reduced risk for prostate cancer. The findings are published online ...

Ovarian cancer discovery deepens knowledge of survival outcomes

2013-12-09
Ovarian cancer discovery deepens knowledge of survival outcomes 10-gene biomarker identified as a tool in evaluating diagnosis, potential response to treatment and overall prognosis LOS ANGELES (Dec. 9, 2013) – Researchers in the Women's Cancer Program at ...

REiNS collaboration seeks common outcome measures for neurofibromatosis clinical trials

2013-12-09
REiNS collaboration seeks common outcome measures for neurofibromatosis clinical trials Initial consensus recommendations for studies of NF appear in special supplement to Neurology Philadelphia, Pa. (December 9, 2013) - As potentially effective new treatments ...

Peaceful bumblebee becomes invasive

2013-12-09
Peaceful bumblebee becomes invasive Bombus terrestris invades South America Bumblebees look cute. They have a thick fur, fly somewhat clumsily and are less aggressive than honeybees or wasps. They are very much appreciated by farmers as keen pollen collectors. ...

Better preparedness against Tamiflu-resistant influenza viruses

2013-12-09
Better preparedness against Tamiflu-resistant influenza viruses Swedish researchers in Umeå and Uppsala have found that residues of the influenza drug Tamiflu in our environment can make the influenza virus in birds resistant. This can have serious ...

How 'good cholesterol' stops inflammation

2013-12-09
How 'good cholesterol' stops inflammation Researchers at the University Hospital and the University of Bonn have discovered a central molecular switch High-density lipoprotein (HDL), known colloquially as "good cholesterol", protects against dangerous deposits ...

ABC transporters enable leaf beetle larvae to accumulate defensive precursors when feeding

2013-12-09
ABC transporters enable leaf beetle larvae to accumulate defensive precursors when feeding Similar membrane proteins play a crucial role in the transport of toxic substances out of the cell This news release is available in German. Scientists ...

LAST 30 PRESS RELEASES:

Cheese may really be giving you nightmares, scientists find

Study reveals most common medical emergencies in schools

Breathable yet protective: Next-gen medical textiles with micro/nano networks

Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems

Developed an AI-based classification system for facial pigmented lesions

Achieving 20% efficiency in halogen-free organic solar cells via isomeric additive-mediated sequential processing

New book Terraglossia reclaims language, Country and culture

The most effective diabetes drugs don't reach enough patients yet

Breast cancer risk in younger women may be influenced by hormone therapy

Strategies for staying smoke-free after rehab

Commentary questions the potential benefit of levothyroxine treatment of mild hypothyroidism during pregnancy

Study projects over 14 million preventable deaths by 2030 if USAID defunding continues

New study reveals 33% gap in transplant access for UK’s poorest children

Dysregulated epigenetic memory in early embryos offers new clues to the inheritance of polycystic ovary syndrome (PCOS)

IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer

It takes a village: Chimpanzee babies do better when their moms have social connections

From lab to market: how renewable polymers could transform medicine

Striking increase in obesity observed among youth between 2011 and 2023

No evidence that medications trigger microscopic colitis in older adults

NYUAD researchers find link between brain growth and mental health disorders

Aging-related inflammation is not universal across human populations, new study finds

University of Oregon to create national children’s mental health center with $11 million federal grant

Rare achievement: UTA undergrad publishes research

Fact or fiction? The ADHD info dilemma

Genetic ancestry linked to risk of severe dengue

Genomes reveal the Norwegian lemming as one of the youngest mammal species

Early birds get the burn: Monash study finds early bedtimes associated with more physical activity

Groundbreaking analysis provides day-by-day insight into prehistoric plankton’s capacity for change

Southern Ocean saltier, hotter and losing ice fast as decades-long trend unexpectedly reverses

Human fishing reshaped Caribbean reef food webs, 7000-year old exposed fossilized reefs reveal

[Press-News.org] EASL publishes revised clinical practice guidelines to optimise the management of hepatitis C virus